Hugh S Markus
Hugh S Markus
Yuan Cai,Vincent Chung Tong Mok,Hugh S Markus
Yuan Cai
There were 56.9 million people worldwide living with dementia in 2021, according to the Global Burden of Disease study, and this number is projected to exceed 137 million by 2050. Vascular dementia (VaD) is the second leading cause of demen...
Cognitive Impairment After Cerebral Venous Thrombosis: A Systematic Review and Meta-analysis [0.03%]
颅静脉血栓形成后认知障碍：系统评价和 meta 分析
Luisa Medeiros Visentini,Gustavo Nascimento de Medeiros,Aluisio D&#x;lucas Alves E Gomes et al.
Luisa Medeiros Visentini et al.
Background: Cerebral venous thrombosis (CVT) is a less common type of stroke that predominantly affects young adults, particularly women. Although CVT is generally associated with more favorable functional outcomes than o...
Ayooluwanimi Peniel Okikiolu,Sucharita Ray,Kamalesh Chakravarty et al.
Ayooluwanimi Peniel Okikiolu et al.
Background: Randomized controlled trials (RCTs) have traditionally been designed with an explanatory approach, in contrast to incorporating real-world, pragmatic considerations. ...
Cerebral venous thrombosis, brain hemorrhage, and does Ayurveda therapy improve outcome after stroke [0.03%]
脑静脉血栓形成和脑出血以及印度阿育吠陀疗法能否改善卒中后的预后
Hugh S Markus
Hugh S Markus
Ticagrelor plus aspirin versus cilostazol plus aspirin in the acute-phase treatment of large-vessel minor stroke or TIA: a randomized controlled multi-center trial, the TACTIS trial [0.03%]
替格瑞洛联合阿司匹林与西洛他唑联合阿司匹林治疗大血管小卒中或TIA急性期的疗效比较：随机对照试验（TACTIS研究）
Mohamed Ismaiel,Sherihan Rezk Ahmed,Mohamed Fouad Elsayed Khalil et al.
Mohamed Ismaiel et al.
IntroductionLarge-vessel occlusion (LVO) stroke represents around one-third of all ischemic strokes; moreover, patients with symptomatic intracranial or extracranial arterial stenosis are at increased risk of stroke occurrence and early str...
Effect of Colchicine for Secondary Prevention according to Stroke Subtype - A Secondary Analysis of the CONVINCE Randomized Trial [0.03%]
依据卒中亚型秋水仙碱二级预防效果的二次分析-一项来自CONVINCE随机试验的分析
Louise Maes,Cathal Walsh,Christian Weimar et al.
Louise Maes et al.
BackgroundThe Colchicine for prevention of vascular inflammation in Non-CardioEmbolic stroke (CONVINCE) trial evaluated long-term treatment with colchicine for the prevention of major adverse cardiovascular events (MACE) in a stroke populat...
Significance of occlusion site on outcomes in stroke patients with large infarction undergoing endovascular therapy: A prespecified subgroup analysis of the ANGEL-ASPECT trial [0.03%]
血管内治疗的大梗死卒中患者良好预后的影像学及临床预测因素：ANGEL-ASPECT试验的预先指定亚组分析
Kangyue Li,Dapeng Sun,Mengxing Wang et al.
Kangyue Li et al.
Background: Randomized studies have demonstrated the efficacy of endovascular therapy (EVT) for acute large vessel occlusion with large infarction. However, the impact of the occlusion site on EVT outcomes remains underex...
Early Versus Delayed Insertable Cardiac Monitor Implantation After ESUS stroke and the Yield of Atrial Fibrillation Detection: a Systematic Review and Meta-analysis [0.03%]
早期与延迟植入可插入型心脏监测仪在ESUS后检测到房颤的阳性率：系统评价和.meta.分析
Lucio D&#x;Anna,Gabriele Prandin,Matteo Foschi et al.
Lucio D&#x;Anna et al.
Background: The clinical utility of implantable cardiac monitors (ICMs) for atrial fibrillation (AF) detection following cryptogenic stroke or embolic stroke of undetermined source (ESUS) is well established. However, the...